Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors including imatinib

Jorge E. Cortes, Franck E. Nicolini, Meir Wetzler, Jeffrey H. Lipton, Luke Akard, Adam Craig, Nisha Nanda, Annie Claude Benichou, Janis Leonoudakis, H. Jean Khoury, Andreas Hochhaus, Michele Baccarani, Hagop M. Kantarjian

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors including imatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences